Sarcoidosis: Historical perspective and immunopathogenesis (part I)

Respiratory Medicine

Volumn 92, Issue 2, 1998, Pages 126-139

  Zissel, G ^a   Muller Quernheim J ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

EPITHELIUM CELL; HISTORY OF MEDICINE; HUMAN; IMMUNOPATHOGENESIS; KVEIM TEST; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; T LYMPHOCYTE; ULTRASTRUCTURE;

EID: 0031905210     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90085-3     Document Type: Review

References (170)

1. Besnier E. Lupus pernio de la face. Ann Derm Syph 1889; 10: 333.
2. Boeck C. Multiple benign sarcoid of the skin. J Cutan Dis 1899; 17: 533.
3. Schaumann J. Sur le lupus pernio 'Mémoire présenté en Novembre 1914 à la Société française de Dermatologie et de Syphiligraphie pour le Prix Zambaco. Stockholm: 1934.
4. Schaumann J. Études sur le lupus pernio et ses raports avec les sarcoides et la tuberculose. Ann Derm Syph 1917; 5: 357.
5. Kuznitzky E, Bittorf A. Boecksches Sarkoid mit Beteiligung innerer Organe. Münch Med Wschr 1915; 62: 1349.
6. Vanek J, Schwarz J. Demonstration of acid-fast rods in sarcoidosis. Am Rev Respir Dis 1970; 101: 395-400.
7. Saboor S, McI. Johnson N, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339: 1012-1015.
8. Mitchell I, Turk J, Mitchell D. Detection of myocobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet 1992; 339: 1015-1017.
9. Bocart D, Lecossier D, de Lassence A, Valeyre D, Battesti J-P, Hance AJ. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 1992; 145: 1142-1148.
10. Joyce-Brady M. Tastes great, less filling. Am Rev Respir Dis 1992; 145: 986-987.
11. Gerdes J, Richter E, Rüsch-Gerdes S et al. Mycobacterial nucleic acids in sarcoid lesions. Lancet 1992; 339: 1536-1537.
12. Badrinas F, Morera J, Fité E, Plasencia A. Seasonal clustering of sarcoidosis. Lancet 1989; 334: 455-456.
13. Parkes S, Baker SB, Bourdillon R, Murray C, Rakshit M. Epidermiology of sarcoidosis in the Isle of Man - 1: A case controlled study. Thorax 1987; 42: 420-426.
14. Kern D, Neill M, Wrenn D, Varone J. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993; 148: 974-980.
15. Edmondstone W. Sarcoidosis in nurses: is there an association? Thorax 1988; 43: 342-343.
16. Burke W, Keogh A, Maloney P, Delprado W, Bryant D, Spratt P. Transmission of sarcoidosis via cardiac transplantation. Lancet 1990; 336: 1579.
17. Hua B, Li QD, Wang FM, Ai CX, Luo WC. Borrelia burgdorferi infection may be the cause of sarcoidosis. Chin Med J 1992; 105: 560-563.
18. Jacob F. Could borrelia burgdorferi be a causal agent of sarcoidosis. Medical Hypotheses 1989; 30: 241-243.
19. Martens H, Zöllner B, Zissel G, Burdon D, Schlaak M, Müller-Quernheim J. Anti-Borrelia burgdorferi immunoglobulin seroprevalence in pulmonary sarcoidosis. Eur Respir J 1997; 10: 1356-1358.
20. Puolakkainen M, Campbell LA, Kuo C-C, Leinonen M, Grönhagen-Riska C, Saikku P. Serological response to Chlamydia pneumoniae in patients with sarcoidosis. J Infection 1996; 33: 199-205.
21. Longcope W, Freiman O. A study of sarcoidosis. Medicine 1952; 31: 132.
22. Williams R. Nickerson D. Skin reactions in sarcoid. Proc Soc Exp Biol Med 1935; 33: 402-405.
23. Kveim A. En ny og spesifik kutan-reakjon ved Boecks sarcoid. (Preliminary report on new and specific cutaneous reaction in Boecks sarcoid). Nord Med 1941; 9: 1969-1972.
24. Chase MW. The preparation and standardization of Kveim testing antigen. Am Rev Respir Dis 1961; 84: 86-88.
25. Siltzbach L. The Kveim test in sarcoidosis. JAMA 1961; 178: 476-482.
26. Lyons D, Donald S. Mitchell D. Asherson G. Chemical inactivation of the Kveim reagent. Respiration 1992; 59: 22-26.
27. Lindahl M, Andersson O, Ripe E, Holm G. Stimulation of bronchoalveolar lavage (BAL) and blood lymphocytes by kveim antigen, tuberculin and concanavalin A in sarcoidosis. Br J Dis Chest 1988; 82: 386-393.
28. Mandell G, Sullivan G. Siltzbach L, Suratt P. In vitro culture of leukocytes from patients with sarcoidosis: in search of an 'in vitro Kveim Test'. Virchows Arch (Cell Pathol) 1981; 35: 201-205.
29. Reutgen H, Eckert H, Christ R. Der Kveimtest in der Sarkoidosediagnostic. Zschr Erkrank Atm org 1988; 170: 306-313.
30. Ishioka S, Fujihara M, Takaishi M, Yamakido M, Hosoda Y. Anti-Kveim monoclonal antibody-new monoclonal antibody reacting to epithelioid cells in sarcoid granulomas. Chest 1990; 98: 1255-1258.
31. Jackson C. Bronchoscopy: past, present, and future. N Engl J Med 1928; 199: 759-763.
32. Myrvik Q, Leake E, Farris B. Studies on pulmonary alveolar macrophages from the normal rabbit: a technique to procure them in a high state of purity. J lmmunol 1961; 86: 128-136.
33. Finley T, Swenson E, Curran W, Haber G. Ladman A. Bronchopulmonary lavage in normal subjects and patients with obstructive lung disease. Ann Intern Med 1967; 66: 651-658.
34. Ikeda S, Yanai N, Ishikawa S. Flexible bronchofiberscope. Keio J Med 1968; 17: 1-16.
35. Weinberger SE, Kelman JA, Elson NA et al. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 1978; 89: 459-466.
36. Reynolds H, Newball H. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974; 84: 559-573.
37. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305: 429-434.
38. Planès C. Valeyre D. Loiseau A, Bernaudin J, Soler P. Ultrastructural alterations of the air-blood barrier in sarcoidosis and hypersensitivity pneumonitis and their relation to lung histopathology. Am J Respir Crit Care Med 1994; 150: 1067-1074.
39. Corrin B, Dewar A, Rodriguez-Roisin R, Turner-Warwick M. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol 1985; 147: 107-119.
40. Crystal R, Ferrans V, Basset F. Biologic basis of pulmonary fibrosis. In: Crystal R, West J, eds. The lung: scientific foundations. New York: Raven Press, 1991: 2031-2046.
41. Fukuda Y, Basset F, Soler P, Ferrans V, Masugi Y, Crystal R. Intraluminal fibrosis and elastic fiber degratation lead to lung remodeling in pulmonary Langerhans cell granulomatosis (histiocytosis X). Am J Pathol 1990; 137: 415-424.
42. Harrison NK, Myers AR, Corrin B et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144: 706-13.
43. Bachofen M, Bachofen H. Parenchymal changes. In: Crystal R, West J, eds. The lung: scientific foundations. New York: Raven Press, 1991: 2019-2030.
44. Fine A, Goldstein R, Snider G. Animal models of pulmonary fibrosis. In: Crystal R, West J, eds. The lung: scientific foundations. New York: Raven Press, 1991: 2047-2057.
45. Woods L, Wilson D, Schiedt M, Giri S. Structural and biochemical changes in lungs of 3-methylindole-treated rats. Am J Pathol 1993; 142: 129-138.
46. +, and albumin concentrations in the alveolar milieu of normal humans and pulmonary sarcoidosis patients. Am Rev Respir Dis 1991; 143: 1096-1101.
47. Weissler J, Mendelson C, Moya F, Yarbrough Jr W. Effect of interstitial lung disease macrophages on T-cell signal transduction. Am J Respir Crit Care Med 1994; 149: 191-196.
48. McCormack FX, King TEJ, Voelker DR, Robinson PC, Mason RJ. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis 1991; 144: 160-6.
49. Ansfield MJ, Benson BJ. Identification of the immunosuppressive components of canine pulmonary surface active material. J Immunol 1980; 122: 125.
50. Hoffman RM, Claypool WD, Katyal SL, Singh G, Rogers RM, Dauber JH. Augmentation of rat alveolar macrophage migration by surfactant protein. Am Rev Respir Dis 1987; 135: 1358-62.
51. Costabel U, Bross KJ, Matthys H. Pulmonary sarcoidosis: Assessment of disease activity by lung lymphocyte subpopulations. Klin Wochenschr 1983; 61: 349-356.
52. Costabel U, Bross KJ, Rühle KH, Lohr GW, Matthys H. Ia-like antigens on T-cells and their subpopulations in pulmonary sarcoidosis and hypersensitivity pneumonitis. Am Rev Respir Dis 1985; 131: 337-342.
53. Saltini C, Hemler ME, Crystal RG. T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1. Clin Immunol Immunopathol 1988; 46: 221-233.
54. Müller-Quernheim J, Krönke M, Strausz J, Schykowski M, Ferlinz R. Interleukin-2 receptor gene expression by bronchoalveolar lavage lymphocytes in pulmonary sarcoidosis. Am Rev Respir Dis 1989; 140: 82-88.
55. duBois RM, Kirby M, Balbi B, Saltini C, Crystal RG. T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor. Am Rev Respir Dis 1992; 145: 1205-1211.
56. Pinkston P, Bitterman PB, Crystal RG, Spontaneous release of interleukin-2 by lung T-lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983; 308: 793-800.
57. Hunninghake GW, Bedel GN, Zavala DC, Monick M, Brady M. Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis. Am Rev Respir Dis 1983; 128: 634-636.
58. Müller-Quernheim J, Saltini C, Sondermeyer P, Crystal RG. Compartmentalized activation of the interleukin-2 gene by lung T-lymphocytes in active pulmonary sarcoidosis. J Immunol 1986; 137: 3475-3483.
59. Curtis J, Kaltreider H. Characterization of bronchoalveolar lymphocytes during a specific antibody-forming cell response in the lungs of mice. Am Rev Respir Dis 1989; 139: 393-400.
60. Saltini C, Spurzem JR, Lee JJ, Pinkston P, Crystal RG. Spontaneous release of interleukin-2 by lung T-lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3 + DR + T-cell subset. J Clin Invest 1986; 77: 1962-1970.
61. Semenzato GC, Trentin AR, Zambello R et al. Evidence of cells bearing interleukin-2 receptor at the sites of disease activity in sarcoid patients. Clin Exp Immunol 1984; 54: 331-337.
62. Hudspith BN, Flint KC, Geraint-James D, Brostoff J, McI Johnson N. Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response. Thorax 1987; 42: 250-255.
63. Burmester G, Jahn B, Gramatzki M, Zacher J, Kalden J. Activated T cells in vivo and in vitro: divergence in expression of Tac and Ia antigens in the nonblastoid small T cells of inflammation and normal T cells activated in vitro. J Immunol 1984; 133: 1230-1234.
64. Hofman FM, von Hanwehr RI, Dinarello GA, Mizel SB, Hinton D, Merrill JE. Immunoregulatory molecules and IL 2 receptors indentified in multiple sclerosis brain. J Immunol 1986; 136: 3239-3245.
65. Paine RI, Mody CH, Chawis A, Spahr MA, Turka LA, Toews GB. Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation. Am J Respir Cell Mol Biol 1991; 5: 221-229.
66. Strauchen JA, Breakstone BA. IL-2 receptor expression in human lymphoid lesions. Am J Pathol 1987; 126: 506-512.
67. Nemoz G, Frigent AF, Aloui R et al. Impaired G-protein and cyclic nucleotide phosphodiesterase activity in T-lymphocytes from patients with sarcoidosis. Eur J Clin Invest 1993; 23: 18-27.
68. Holter J, Park H, Sjoerdsma K, Kataria Y. Nonviable autologous bronchoalveolar lavage cell preparations induce intradermal epithelioid cell granulomas in sarcoidosis patients. Am Rev Respir Dis 1992; 145: 864-871.
69. Moller DR, Konishi K, Kirby M, Balbi B, Crystal RG. Bias toward use of a specific T-cell receptor β-chain variable region in a subgroup of individuals with sarcoidosis. J Clin Invest 1988; 82: 1183-1191.
70. Grunewald J, Olerup O, Persson U, Öhrn BM, Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA 1994; 91: 4965-4969.
71. Forman J, Klein J, Silver R, Liu M, Greenlee B, Moller D. Selective activation and accumulation of oligoclonal Vβ-specific T cells in active pulmonary sarcoidosis. J Clin Invest 1994; 94: 1533-1542.
72. Tamura N, Moller D, Balbi B, Crystal R. Preferential usage of the T-cell antigen receptor beta-chain constant region C beta 1 element by lung T-lymphocytes of patients with pulmonary sarcoidosis. Am Rev Respir Dis 1991; 143: 635-639.
73. Zissel G, Bäumer I, Fleischer B, Schlaak M, Müller-Quernheim J. The T-cell antigen receptor Vβ family repertoire of T cell clones from lung parenchyma in comparison with other body compartments of patients with sarcoidosis. Am J Crit Care Med 1997; 156: 1593-1600.
74. Bellocq A, Lecossier D, Pierre-Audigier C, Tazi A, Valeyre D, Hance AJ. T cell receptor repertoire of T lymphocytes recovered from the lung and blood of patients with sarcoidosis. Am J Respir Crit Care Med 1994; 149: 646-654.
75. Dohi M, Yamamoto K, Masuko K et al. Accumulation of multiple T cell clonotypes in lungs of healthy individuals and patients with pulmonary sarcoidosis. J Immunol 1994; 152: 1983-1988.
76. Klein J, Horn T, Forman J, Silver R, Tierstein A, Moller D. Selection of oligoclonal Vβ-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol 1995; 154: 1450-1460.
77. Silver RF, Crystall RG, Moller DR. Limited heterogeneity of biased T-cell receptor Vβ gene usage in lung but not blood T cells in active pulmonary sarcoidosis. Immunology 1996; 88: 516-523.
78. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357.
79. Florentine DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
80. Romagnani S. Human Th1 and Th2 subsets: doubt no more. Immunol Today 1991; 12: 256-257.
81. Robinson BWS, McLemore T, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T-lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985; 75: 1488-1495.
82. Hoshino T, Itoh K, Gouhara R et al. Spontaneous production of various cytokines except IL-4 from CD4+ T cells in the affected organs of sarcoidosis patients. Clin Exp Immunol 1995; 102: 399-405.
83. Walker C, Bauer W, Braun R et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150: 1038-1048.
84. Bäumer I, Zissel G, Schlaak M, Muller-Quernheim J. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1997; 16: 171-177.
85. Gratters JC, Drent M, van Velzen-Blad H, van den Bosch JMM. Improvement of bronchial asthma during an episode of active sarcoidosis. A case report. Am J Respir Crit Care Med 1996; 153: A282.
86. Balbi B, Moller DR, Kirby M, Holrody KJ, Crystal RG. Increased numbers of T-lymphocytes with γδ-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis. J Clin Invest 1990; 85: 1353-1361.
87. Pfeifer S, Müller-Quernheim J. Subtypisierung von T-Lymphozyten bei Sarkoidose. Pneumologie 1994; 48: 427-432.
88. Raulf M, Liebers V, Steppert C, Baur X. Increased γ/δ-positive T-cells in blood and bronchoalveolar lavage of patients with sarcoidosis and hypersensitivity pneumonitis. Eur Respir J 1994; 7: 140-147.
89. Balbi B, Valle M, Oddera S et al. T-lymphocytes with γδ + Vδ2 + antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidois. Am Rev Respir Dis 1993; 148: 1685-1690.
90. Forrester J, Newman L, Wang Y, King T, Kotzin B. Clonal expansion of lung Vδ1 + cells in pulmonary sarcoidosis. J Clin Invest 1993; 91: 292-300.
91. Tazi A, Fajac I, Soler P, Valeyre D, Battesti JP, Hance AJ. γδ T-lymphocytes are not increased in number in granulomatous lesions of patients with tuberculosis or sarcoidosis. Am Rev Respir Dis 1991; 144: 1373-1376.
92. Rao N, Naidu Y, Bell R et al Usage of T cell receptor β-chain variable gene is highly restricted at the site of inflammation in murine autoimmune uveitis. J Immunol 1993; 150: 5716-5721.
93. Jenkins R, Nikaein A, Zimmermann A, Meek A, Lipsky P. T cell receptor Vβ gene bias in rheumatoid arthritis. J Clin Invest 1993; 92: 2688-2701.
94. Posnett DN, Schmelkin I, Burton DA, August A, McGrath H, Mayer LF. T cell antigen receptor V gene usage. Increases in Vβ8+T-cells in Crohn's disease. J Clin Invest 1990; 85: 1770-1776.
95. Kiemle-Kallee J, Kreipe H, Radzun HJ, et al. Alveolar macrophages in idiopathic pulmonary fibrosis display a more monocyte-like immunophenotype and an increased release of free oxygen radicals. Eur Respir J 1991; 4: 400-406.
96. Hance AJ, Douches S, Winchester RJ, Ferrans VJ, Crystal RG. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: Changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J Immunol 1985; 134: 284-292.
97. Hunninghake G, Glazier A, Monick M, Dinarello C. Interleukin-1 is a chemotactic factor for human T-lymphocytes. Am Rev Respir Dis 1987; 135: 66-71.
98. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, Walz A. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994; 149: 655-659.
99. Standiford T, Rolfe M, Kunkel S, et al. Macrophage inflammatory protein-1 a expression in interstitial lung disease. J Immunol 1993; 151: 2852-2863.
100. Ming JW, Bersani L, Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 1987; 138: 1469-1474.
101. Striz I, Wang J, Teschler H, Sorg C, Costabel U. Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis. Lung 1993; 171: 293-303.
102. Hunninghake GW. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Am Rev Respir Dis 1984; 129: 569-572.
103. Strausz J, Männel D, Pfeifer S, Borkowski A, Ferlinz R, Müller-Quernheim J. Spontaneous monokine release by alveolar macrophages in chronic sarcoidosis. Int Archs Allergy Appl Immun 1991; 96: 68-75.
104. Müller-Quernheim J, Pfeifer S, Männel D, Strausz J, Ferlinz R. Lung restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992; 145: 187-192.
105. Steifen M, Petersen J, Oldigs M et al. Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. Chest 1993; 91: 939-949.
106. Terao I, Hashimoto S, Horie T. Effect of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis. Int Arch Allergy Immunol 1993; 102: 242-248.
107. Wewers MD, Saltini C, Sellers S et al. Evaluation of alveolar macrophages in normals and individuals with active pulmonary sarcoidosis for the spontaneous expression of interleukin-1β gene. Cell Immunol 1987; 107: 479-488.
108. Rolfe MW, Standiford TJ, Kunkel SL et al. Interleukin-1 receptor antagonist expression in sarcoidosis. Am Rev Respir Dis 1993; 148: 1378-1384.
109. Nagai S, Aung H, Takeuchi M, Kusume K, Izumi T. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases. Chest 1991; 99: 674-680.
110. Homolka J, Müller-Quernheim J. Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis. Lung 1993; 171: 173-183.
111. Baughman RP, Strohofer SA, Buchsbaum J, Lower EE. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med 1990; 115: 36-42.
112. Kunkel SL, Remick DG, Strieter RM, Larrick JW. Mechanisms that regulate the production and effects of tumor necrosis factor-a. Crit Rev Immunol 1989; 9: 93-117.
113. Foley N, Lambert C, McNicol M, Johnson N, Rook GAW. An inhibitor of the toxicity of tumor necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease. Clin Exp Immunol 1990; 80:.
114. Zitnik R, Elias JA. Interleukin-6 and the lung. In: Kelley J, ed. Cytokines of the lung. New York: Marcel Dekker, 1993: 229-280. (Lenfent C, ed. Lung biology in health and disease;
115. Dayer JM. Cytokines and cytokine inhibitors in inflammation. Eur Respir J 1990; 3 (Suppl. 10): 178s.
116. Seckinger P, Zhang JH, Hauptmann B, Dayer JM. Characterisation of tumor necrosis factor α (TNF-α) inhibitor: Evidence of immunological cross-reactivity with the TNF receptor. Proc Natl Acad Sci USA 1990; 87: 5188-5192.
117. Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 316: 379-385.
118. Chilosi M, Menestrina F, Capelli P et al. Immuno-histochemical analysis of sarcoid granulomas. Evaluation of Ki 67+ and Interleukin-1+ cells. Am J Pathol 1988; 131: 191-198.
119. Devergne O, Emilie D, Peuchmaur M, Crevon MC, D'Agay MF, Galanaud P. Production of cytokines in sarcoid lymph nodes: Preferential expression of interleukin-1β and Interferon-γ genes. Hum Pathol 1992; 23: 317-323.
120. Asano M, Minagawa T, Ohmichi M, Hiraga Y. Detection of endogenous cytokines in sera or in lymph nodes obtained from patients with sarcoidosis. Clin Exp Immunol 1991; 84: 92-96.
121. Lohmann-Matthes M, Steinmüller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994; 7: 1678-1689.
122. Nicod LP, Lipscomb MF, Weissler JC, Lyons CR, Alberton J, Toews GB. Mononuclear cells in human lung parenchyma. Characterization of a potent accessory cell not obtained by bronchoalveolar lavage. Am Rev Respir Dis 1987; 136: 818-823.
123. Fels A, Cohn Z. The alveolar macrophage. J Appl Physiol 1986; 60: 353-369.
124. Toews GB, Lern VM, Weissler JC et al. Antigen presentation by alveolar macrophages in patients with sarcoidosis. Ann NY Acad Sci 1986; 465: 74-81.
125. Lern VM, Lipscomb MF, Weissler JC et al. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation. J Immunol 1985; 135: 1766-1771.
126. Wewers MD, Rennard SI, Hance AJ, Bitterman PB, Crystal RG. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. J Clin Invest 1984; 74: 2208-2218.
127. Venet A, Hance AJ, Saltini C, Robinson BWS, Crystal RG. Enhanced alveolar macrophage-mediated antigen-induced T lymphocyte proliferation in sarcoidosis. J Clin Invest 1985; 75: 293-301.
128. Zissel G, Ernst M, Schlaak M, Müller-Quernheim J. Accessory function of alveolar macrophages from patients with sarcoidosis and other granulomatous and non-granulomatous lung diseases. J. Invest Med 1997; 45: 75-86.
129. Watts TH, Alaverdi N, Wade WF, Linsley PS. Induction of costimulatory molecule B7 in M12 B lymphoma by cAMP or MHC-restricted T cell interaction. J Immunol 1993; 150: 2192-2202.
130. Nabavi N, Freeman GJ, Gault A, Godfrey D, Nadler LM. Glimcher LH. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 1992; 360: 266-268.
131. Zissel G, Aulitzky W, Lorenz J, Huber C, Müller-Quernheim J. Induction of accessory cell function of human alveolar macrophages by inhalation of human natural interleukin-2. Cancer Immunol Immunotherapy 1996; 2: 122-126.
132. Reiser H, Stadecker MJ. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 1996; 335: 1369-1377.
133. Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707-718.
134. Racke MK, Scott DE, Quigley L et al. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the inhibition of experimental allergic encephalomyelitis. J Clin Invest 1995; 96: 2195-2203.
135. Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 1995; 81: 979-82.
136. Aerts C, Wallaert JM, Grosbois JM, Voisin C. Release of Superoxide anion by alveolar macrophages in pulmonary sarcoidosis. Ann NY Aca Science 1986; 465: 193-200.
137. Barth J, Entzian P, Petermann W. Increased release of free radicals by phagocytosing and non-phagocytosing cells from patients with active pulmonary sarcoidosis as revealed by luminol-dependent chemiluminescence. Klin Wochenschr 1988; 66: 292-297.
138. Kanegasaki S, Homma JY, Homma H, Washizaki M. Enhanced chemiluminescence response of phagocyting monocytes from sarcoidosis patients. Int Arch Allergy Immunol 1981; 64: 72-79.
139. Martin RR, Lawrence EC, Teague RB, Gottlieb MS, Putman M. Chemiluminescence of lung macrophages and blood leukocytes in sarcoidosis. Am Rev Respir Dis 1986; 133: 298-301.
140. Strausz J, Müller-Quernheim J, Steppling H, Borkowski A, Ferlinz R. Sauerstoffradikalproduktion alveolärer Entzündungszellen bei Sarkoidose und idiopathischer Lungenfibrose. Pneumologie 1989; 43: 440-445.
141. Fels AOS, Nathan CF, Cohn ZA. Hydrogen peroxide release by alveolar macrophage from sarcoid patients and by alveolar macrophage from normals after exposure to recombinant interferon α, β, and γ and 1,25-dihydroxyvitamin D3. J Clin Invest 1987; 80: 381-386.
142. Schaberg T, Rau M, Stephan H, Lode H. Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic fibrosis is related to the production of Superoxide anions by these cells. Am Rev Respir Dis 1993; 147: 1507-1513.
143. Maier K, Leuschel L, Costabel U. Increased levels of oxidized methionine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 143: 271-274.
144. Behr J, Maier K, Krombach F, Adelmann-Grill BC. Pathogenetic significance of reactive oxygen species in diffuse fibrosing alveolitis. Am Rev Respir Dis 1991; 144: 146-150.
145. Strausz J, Muller-Quernheim J, Steppling H, Ferlinz R. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1990; 141: 124-128.
146. Cantin AM, North SL, Fells GA, Hubbard RC, Crystal RG. Oxydant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest 1987; 79: 1665-1673.
147. Borok Z, Buhl R, Grimes GJ et al. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 1991; 338: 215-216.
148. Buhl R, Vogelmeier C, Critenden M et al. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc Natl Acad Sci USA 1990; 87: 4063-4067.
149. Meyer A, Buhl R, Magnussen H. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 1994; 7: 431-436.
150. Peters U, Papadopoulos T, Müller-Hermelink H. MHC class II antigens on lung epithelia of human fetuses and neonates. Ontogeny and expression in lungs with histologie evidence of infection. Lab Invest 1990; 63: 38-43.
151. Papadopoulos T, Sirtl K, Dämmerich J, Müller-Hermelink H. Expressionsmuster von Integrinen auf Alveolarepithelien in der fetalen und adulten Lunge und bei interstitiellen Lungenerkrankungen. Verh Dtsch Ges Path 1993; 77: 292-295.
152. Guzman J, Izumi T, Nagai S, Costabel U. ICAM-1 and intergrin expression on isolated human alveolar type II pneumocytes. Eur Respir J 1994; 7: 736-739.
153. Zissel G, Ernst M, Rabe KH, Magnussen H, Schlaak M. Adhesion molecules and accessory cell function of alveolar epithelial cells type II (AEC-II). Eur Respir J 1996; 9: 411s.
154. Limper A, Colby V, Sanders M, Asakura S, Roche P, DeRemee R. Immunohistochemical localization of transforming growth factor-β1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994; 149: 197-204.
155. Kohno N, Awaya Y, Oyama T et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993; 148: 637-642.
156. Kallenberg C, Schilizzi B, Beaumont F, de Leij L, Poppema S, The T. Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis. J Clin Pathol 1987; 40: 725-733.
157. Papadopoulos T, Ionescu L, Dämmrich J, Toomes H, Müller-Hermelink H. Type I and type IV collagen promote adherence and spreading of human type II pneumocytes in vitro. Lab Invest 1990; 62: 562-569.
158. Bitterman PB, Wewers WD, Rennard SI, Adelberg S, Crystal RG. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest 1986; 77: 700-708.
159. Martinet Y, Rom WN, Grotendorst GR, Martin GR, Crystal RG. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 1987; 317: 202-209.
160. Weissler J. Idiopathic pulmonary fibrosis: Cellular and molecular pathogenesis. Am J Med Sci 1989; 279: 91-104.
161. Pulunovsky V, Chen B, Henke C et al. Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest 1993; 92: 388-397.
162. D'Andrea R, Rengaraju M, Valiante NM et al. Production of natural killer cell stimulatory factor (Interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992; 176: 1387-1398.
163. Moller DR, Forman JD, Liu MC et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996; 156: 4952-4960.
164. Wahl SM, McCartney-Francis N, Mergenhagen S. Inflammatory and immunoregulatory roles of TGF-β. Immunol Today 1989; 10: 258-261.
165. + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur J Immunol 1994; 24: 793-798.
166. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunpathol 1996; 80: 225-235.
167. Nagelkerken L, Gollob KJ, Tielemans M, Coffman RL. Role of transforming growth factor-β in the preferential induction of T helper cells of type 1 by staphylococcal enteroxin B. Eur J Immunol 1993; 23: 2306-2310.
168. deWaal Malefyt R, Haanen J, Spits HF et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompability complex expression. J Exp Med 1991; 174: 915-924.
169. Zissel G, Homolka J, Schlaak J, Schlaak M, Müller-Quernheim J. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am J Respir Crit Care Med 1996; 154: 713-719.
170. Koberda J, Grimm E, Moser R. Effect of anti-CD3/ anti-CD28/interleukin-2 stimulation of mononuclear cells on transforming growth factor β inhibition of lymphokine-activated killer cell generation. J Can Res Clin Oncol 1993; 119: 131-136.